DHARMAJ
Dharmaj Crop Guard Limited
Agrochemical formulations including insecticides, fungicides and herbicides
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
dharmajcrop.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Dharmaj Crop Guard makes and sells crop protection products such as insecticides, fungicides, herbicides, plant growth regulators and micro fertilisers.
Company snapshot
18thBy market cap
Ranked among 23 companies in Pesticides & Agrochemicals.
What we see
- ✓Debt-to-equity of 0.29x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Sales | 210 Cr | 367 Cr | 347 Cr | 190 Cr | 234 Cr | 382 Cr |
| Operating expenses (approx.) | 206 Cr | 317 Cr | 315 Cr | 182 Cr | 223 Cr | 325 Cr |
| EBITDA | 4 Cr | 51 Cr | 32 Cr | 7 Cr | 11 Cr | 57 Cr |
| OPM % | 1.8% | 13.8% | 9.2% | 3.9% | 4.5% | 15.0% |
| Other income | 2 Cr | 0.77 Cr | 0.04 Cr | 3 Cr | 4 Cr | 1 Cr |
| Interest | 4 Cr | 3 Cr | 5 Cr | 5 Cr | 5 Cr | 3 Cr |
| Depreciation | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr |
| Profit before tax | -3 Cr | 44 Cr | 23 Cr | 0.97 Cr | 5 Cr | 51 Cr |
| Tax % | 23.2% | 25.5% | 23.1% | 22.3% | 24.2% | 25.3% |
| Net profit | -2 Cr | 33 Cr | 17 Cr | 0.76 Cr | 4 Cr | 38 Cr |
| EPS (₹) | ₹-0.73 | ₹9.64 | ₹5.13 | ₹0.22 | ₹1.17 | ₹11.28 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 951 Cr | 1,138 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 876 Cr | 1,037 Cr | Sign in free for the trailing twelve months |
| EBITDA | 75 Cr | 100 Cr | Sign in free for the trailing twelve months |
| OPM % | 7.9% | 8.8% | Sign in free for the trailing twelve months |
| Other income | 2 Cr | 8 Cr | Sign in free for the trailing twelve months |
| Interest | 13 Cr | 17 Cr | Sign in free for the trailing twelve months |
| Depreciation | 18 Cr | 19 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 46 Cr | 72 Cr | Sign in free for the trailing twelve months |
| Tax % | 23.9% | 24.6% | Sign in free for the trailing twelve months |
| Net profit | 35 Cr | 55 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹10.30 | ₹16.17 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 34 Cr | 34 Cr |
| Reserves | 361 Cr | 415 Cr |
| Borrowings | 116 Cr | 132 Cr |
| Other liabilities | 223 Cr | 260 Cr |
| Total liabilities | 733 Cr | 841 Cr |
| Fixed assets (net) | 308 Cr | 310 Cr |
| CWIP | 3 Cr | 6 Cr |
| Investments | 0 Cr | 0 Cr |
| Loans & advances | 0.06 Cr | 0.02 Cr |
| Inventories | 138 Cr | 207 Cr |
| Trade receivables | 248 Cr | 281 Cr |
| Cash & bank | 0.23 Cr | 0.28 Cr |
| Other assets | 35 Cr | 37 Cr |
| Total assets | 733 Cr | 841 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operating activity | 39 Cr | 28 Cr |
| Cash from investing | -33 Cr | -29 Cr |
| Cash from financing | -9 Cr | 2 Cr |
| Net cash flow | -3 Cr | 0.05 Cr |
| Free cash flow (OCF − Capex) | 7 Cr | 0.69 Cr |
Ratios
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | 11.5% | 15.4% |
| ROE % | 8.8% | 12.2% |
| Debtor days | 95 | 90 |
| Inventory days | 85 | 107 |
| Days payable | 120 | 112 |
| Cash conversion cycle | 60 | 86 |
| OCF / EBITDA % | 51.7% | 27.5% |
| Debt / equity | 0.29 | 0.29 |
| Current ratio | 1.53 | 1.55 |
| Net debt / EBITDA | 1.54 | 1.31 |